Cargando…
β-Eudesmol Inhibits the Migration of Cholangiocarcinoma Cells by Suppressing Epithelial-Mesenchymal Transition via PI3K/AKT and p38MAPK Modulation
BACKGROUND: Cholangiocarcinoma (CCA) is a highly aggressive tumor with a greater risk of distant metastasis. A drug that prevents CCA development and spread is urgently needed. In this research, we investigated the effect of β-eudesmol on the migration and invasion and epithelial-mesenchymal transfo...
Autores principales: | Acharya, Bishwanath, Chaijaroenkul, Wanna, Na-Bangchang, Kesara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
West Asia Organization for Cancer Prevention
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9741878/ https://www.ncbi.nlm.nih.gov/pubmed/36037109 http://dx.doi.org/10.31557/APJCP.2022.23.8.2573 |
Ejemplares similares
-
The Proteomics and Metabolomics Analysis for Screening the Molecular Targets of Action of β-Eudesmol in Cholangiocarcinoma
por: Kotawong, Kanawut, et al.
Publicado: (2021) -
Atractylodin and β-eudesmol from Atractylodes lancea (Thunb.) DC. Inhibit Cholangiocarcinoma Cell Proliferation by Downregulating the Notch Signaling Pathway
por: Vanaroj, Peeranate, et al.
Publicado: (2023) -
β-Eudesmol induces the expression of apoptosis pathway proteins in cholangiocarcinoma cell lines
por: Narahara, Chisato, et al.
Publicado: (2020) -
Proteomics Analysis for Identification of Potential Cell Signaling Pathways and Protein Targets of Actions of Atractylodin and β-Eudesmol Against Cholangiocarcinoma
por: Kotawong, Kanawut, et al.
Publicado: (2020) -
Effect of β-Eudesmol on NQO1 suppression-enhanced sensitivity of cholangiocarcinoma cells to chemotherapeutic agents
por: Srijiwangsa, Pimradasiri, et al.
Publicado: (2018)